Detalhe da pesquisa
1.
Obesity: a gender-view.
J Endocrinol Invest
; 47(2): 299-306, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740888
2.
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center.
J Endocrinol Invest
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532073
3.
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs.
J Endocrinol Invest
; 47(3): 683-697, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695461
4.
Role of Mediterranean diet in endocrine diseases: a joint overview by the endocrinologist and the nutritionist.
J Endocrinol Invest
; 47(1): 17-33, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697017
5.
Ketogenic nutritional therapy (KeNuT)-a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-diet therapies in endocrinology and metabolism.
J Endocrinol Invest
; 47(3): 487-500, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238506
6.
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome.
J Endocrinol Invest
; 47(3): 655-669, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682493
7.
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy.
J Endocrinol Invest
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214852
8.
Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
J Endocrinol Invest
; 46(4): 667-677, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526827
9.
Parathyroid diseases and metabolic syndrome.
J Endocrinol Invest
; 46(6): 1065-1077, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773188
10.
Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience.
J Endocrinol Invest
; 46(5): 1027-1038, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892739
11.
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
J Endocrinol Invest
; 46(9): 1761-1774, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093453
12.
Weight stigma speaks Italian, too.
J Endocrinol Invest
; 46(4): 787-794, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441505
13.
Short-time effects of ketogenic diet or modestly hypocaloric Mediterranean diet on overweight and obese women with polycystic ovary syndrome.
J Endocrinol Invest
; 46(4): 769-777, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36401759
14.
Vitamin D and chronotype: is there any relationship in individuals with obesity?
J Endocrinol Invest
; 46(5): 1001-1008, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454438
15.
Effects of very low-calorie ketogenic diet on hypothalamic-pituitary-adrenal axis and renin-angiotensin-aldosterone system.
J Endocrinol Invest
; 46(8): 1509-1520, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017918
16.
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.
J Endocrinol Invest
; 46(11): 2275-2286, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002436
17.
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
J Endocrinol Invest
; 46(2): 213-234, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36038743
18.
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study.
J Endocrinol Invest
; 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837555
19.
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study.
Pituitary
; 25(6): 982-987, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260240
20.
The dopaminergic control of Cushing's syndrome.
J Endocrinol Invest
; 45(7): 1297-1315, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460460